Binding and pharmacologic properties of peptides derived from human and rat angiotensin II (AII) mRNA
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 170 (2) , 462-469
- https://doi.org/10.1016/0006-291x(90)92114-f
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II actionBiochemical Journal, 1989
- Are the antibodies to a peptide complementary to angiotensin II useful to isolate the angiotensin II receptor?Biochemical Journal, 1989
- ‘Complementary peptides’: a responseBiochemical Journal, 1989
- Angiotensin ‘antipeptides’: (−)messenger RNA complementary to human angiotensin II (+)messenger RNA encodes an angiotensin receptor antagonistBiochemical and Biophysical Research Communications, 1989
- The use of complementary peptides in the purification of an angiotensin II binding proteinJournal Of Hypertension, 1988
- Immunocytochemistry of a vasopressin (AVP) receptor with anti-idiotype antibody: Inhibition of staining with a peptide (PVA) encoded by an RNA that is complementary to AVP mRNANeuroscience Letters, 1988
- Primary structure of human preangiotensinogen deduced from the cloned cDNA sequenceBiochemistry, 1984
- Hydropathic anti-complementarity of amino acids based on the genetic codeBiochemical and Biophysical Research Communications, 1984
- Amphiphilic Secondary Structure: Design of Peptide HormonesScience, 1984
- Regulation of angiotensin II receptors in the rat adrenal cortex by dietary electrolytes.Journal of Clinical Investigation, 1976